Advances in Prostate Biopsy: From Innovative Imaging Modalities to Optimized Detection Strategies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 1 November 2025 | Viewed by 567
Special Issue Editor
2. Department of Medicine (DIMED), University of Padua, 35128 Padova, Italy
Interests: prostate cancer; biopsy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
(1) Introduction
Prostate cancer remains one of the most prevalent malignancies in men worldwide, and early detection plays a pivotal role in improving patient outcomes. Prostate biopsy is a key diagnostic procedure; however, its practice has been continually refined to enhance accuracy and minimize risks. The advent of advanced imaging modalities, such as PSMA PET, has opened new avenues for the more precise targeting of suspicious lesions. Simultaneously, the debate around systematic versus targeted biopsies challenges traditional protocols. With the growing role of transperineal biopsies and emerging markets for PCa detection technologies, it is imperative to critically appraise the latest evidence and guide future research and clinical practice. This Special Issue aims to provide new insights into the optimization of prostate biopsies, addressing current controversies and exploring cutting-edge advancements. Topics will include the role of imaging-guided biopsies, the benefits and drawbacks of transrectal versus transperineal approaches, the utility of perilesional sampling, and the economic considerations of biopsy protocols. Furthermore, it will delve into emerging technologies in PCa detection and their implications for clinical practice.
We are pleased to invite you to contribute to this Special Issue, which will serve as a platform to consolidate and expand our understanding of prostate biopsy techniques and strategies.
(2) Aim of the Special Issue
This Special Issue aims to explore contemporary advancements and address ongoing challenges in prostate biopsies. Within the journal’s scope, this collection will bring together research and reviews that cover technological innovations, procedural approaches, cost-effectiveness, and clinical implications in prostate cancer detection. With a focus on practical and translational aspects, this Special Issue will provide a comprehensive resource for clinicians, researchers, and industry stakeholders.
(3) Suggested Themes and Article Types
This collection seeks to foster collaboration and discussion among clinicians, researchers, and policymakers, paving the way for evidence-based improvements in prostate biopsy techniques and patient outcomes. Contributions in the form of original research articles and comprehensive reviews are welcome. In this Special Issue, we welcome original research articles, reviews, and case studies in the following areas:
- The role of PSMA PET and other imaging modalities in prostate biopsies;
- Systematic biopsies vs. targeted biopsies: pros, cons, and clinical outcomes;
- The utility and rationale for perilesional biopsies;
- Comparative analysis of transrectal and transperineal biopsy approaches;
- Economic evaluations and cost-effectiveness of prostate biopsy protocols;
- Emerging technologies and markets to improve prostate cancer detection;
- Patient-centric approaches and minimizing complications in biopsy procedures;
- Future perspectives and guidelines for prostate biopsy practices.
We look forward to receiving your contributions and working together to create a valuable collection of insights and evidence.
Dr. Fabio Zattoni
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate biopsy
- PSMA PET
- systematic biopsies
- targeted biopsies
- transrectal biopsies
- transperineal biopsies
- cost-effectiveness
- perilesional biopsy
- PCa detection
- imaging modalities
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
